Phosphodiesterase inhibitory properties of losartan. design and synthesis of new lead compounds
摘要:
A 4-centre PDE 4 pharmacophore search has been carried out in several 3D-databases containing compounds belonging to different therapeutic areas. Losartan, an angiotensin-II antagonist, has been identified as a new lead compound for developping PDE 4 inhibitors. New families of compounds derived from losartan has been synthesized and their PDE inhibition has been measured. (C) 1998 Elsevier Science Ltd. All rights reserved.
A 4-centre PDE 4 pharmacophore search has been carried out in several 3D-databases containing compounds belonging to different therapeutic areas. Losartan, an angiotensin-II antagonist, has been identified as a new lead compound for developping PDE 4 inhibitors. New families of compounds derived from losartan has been synthesized and their PDE inhibition has been measured. (C) 1998 Elsevier Science Ltd. All rights reserved.
Intramolecular oxidative cyclizations in heteroarylthioureas: A versatile pathway to bridgehead heterocyclic systems
作者:Ana Castro、Ana Martinez
DOI:10.1002/jhet.5570360427
日期:1999.7
Intramolecularoxidations in N-alkyl-N'-heteroarylthioureas represent a facile and versatile synthetic pathway to fused heterocyclicsystems including the bridgehead ones. This kind of heterocycles are the main feature in commom biologically active compounds.